Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income (loss)	$ (153,178)	$ 297,020
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on marketable securities held in trust account	(46,244)	(301,779)
Unrealized gain on marketable securities held in trust account	(24,398)	(157,060)
Amortization	25,287	1,875
Net changes in operating assets & liabilities:
Prepaid expenses	(86,306)	(600)
Due to Sponsor	229,670	54,000
Accrued expenses	55,169	106,544
Net cash used in operating activities
Cash flows from investing activities:
Investment of cash in trust account	(150,000)	(250,000)
Cash withdrawn from trust account to redeem public shares
Net cash used in investing activities	(150,000)	(250,000)
Cash flows from financing activities:
Proceeds of Sponsor loan	150,000	250,000
Net cash provided by financing activities	150,000	250,000
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of non-cash investing and financing activities:
Subsequent measurement of ordinary shares subject to redemption (interest earned, unrealized gain on trust account and additional funding for business combination extension)	$ 220,642	$ 608,839